echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Alzheimers & Dementia: Controlling pressure in middle-aged people to prevent dementia-middle-aged vascular risk factors and the risk of occasional dementia

    Alzheimers & Dementia: Controlling pressure in middle-aged people to prevent dementia-middle-aged vascular risk factors and the risk of occasional dementia

    • Last Update: 2021-11-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Dementia is a major public health problem that places a heavy burden on patients, caregivers and the national healthcare system
    .


    The pathophysiological process leading to dementia begins before the patient develops clinically identifiable cognitive deficits in his later years


    Dementia is a major public health problem that places a heavy burden on patients, caregivers and the national healthcare system


    Several cohort studies have explored the relationship between LS7 scores and the risk of Alzheimer’s or cognitive decline, but the results are not consistent


    Mendelian randomization (MR) uses gene variants associated with exposure of interest as a tool and investigates their relationship with disease outcomes, thereby overcoming some of the key limitations of observational research, such as confusion and reverse causes


    Recently, researchers have used the large-scale LS7 data of 230,000 individuals between the ages of 40 and 69 from the UK Biobank (UKB) to track for 12 years: (1) Determine the baseline, that is, the score and its The relationship between biological and life>


    In 229,976 people (with an average follow-up of 9 years), the researchers explored whether middle-aged cardiovascular health measured by the LS7 scale is related to sudden all-cause dementia, and whether the various components of the score are causally related to dementia
    .

    In 229,976 people (with an average follow-up of 9 years), the researchers explored whether middle-aged cardiovascular health measured by the LS7 scale is related to sudden all-cause dementia, and whether the various components of the score are causally related to dementia
    .


     

    • Adherence to the biological indicators of LS7 (blood pressure, cholesterol, blood sugar levels) is associated with a lower risk of dementia (hazard ratio=0.
      93 for every 1 point increase, 95% confidence interval [CI; 0.
      89-0.
      96])
      .
    • In contrast, the LS7 composite score was not associated with life>
      .
    • In a Mendelian randomized analysis, genetic hypertension was associated with an increased risk of dementia (odds ratio = 1.
      31 per standard deviation increase, 95% CI [1.
      05-1.
      60])
      .
  • Adherence to the biological indicators of LS7 (blood pressure, cholesterol, blood sugar levels) is associated with a lower risk of dementia (hazard ratio=0.
    93 for every 1 point increase, 95% confidence interval [CI; 0.
    89-0.
    96])
    .
  • Adherence to the biological indicators of LS7 (blood pressure, cholesterol, blood sugar levels) is associated with a lower risk of dementia (hazard ratio=0.
    93 for every 1 point increase, 95% confidence interval [CI; 0.
    89-0.
    96])
    .


  • In contrast, the LS7 composite score was not associated with life>


     These findings underscore the importance of controlling blood pressure in middle age to reduce the risk of dementia


    Literature source: https://doi.
    80599.
    net/10.
    1002/alz.
    12320 https://doi.
    80599.
    net/10.
    1002/alz.
    12320 Leave a message here
  • This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.